html5-img
1 / 19

AUDIT OF BOTOX INJECTION IN CEREBRAL PALSY CHILDREN

AUDIT OF BOTOX INJECTION IN CEREBRAL PALSY CHILDREN. 1 st February 08 - 1 st February 09 Wigan Dr T Win, Dr J Agbenu. Botox injection. Botulinum toxin type A – toxin produced by Clostridium botulinum .

cherie
Télécharger la présentation

AUDIT OF BOTOX INJECTION IN CEREBRAL PALSY CHILDREN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. AUDIT OF BOTOX INJECTION IN CEREBRAL PALSY CHILDREN 1st February 08 - 1st February 09 Wigan Dr T Win, Dr J Agbenu

  2. Botox injection • Botulinum toxin type A – toxin produced by Clostridium botulinum. • Protein composed of heavy chain (molecular weight – 100,000) and light chain (50,000). • Heavy chain binds nerve terminal at neuromuscular junction. • Light chain is transported into the nerve terminals and blocks the release of Acetylcholine presynaptically, thereby weakening the force of muscle contraction.

  3. Botox injection • An appropriate candidate for Botox injection will derive functional benefit from this- • Weakening of overactive agonist muscles should facilitate improve range of motion and limb function while rehabilitative exercises strengthen antagonist muscles and cultivate propioceptive map of the limb. • BOTOX – powder for reconstitution botulinum A neurotoxin complex. (100 units vial =GBP128.93)

  4. Tone management Pathway

  5. Number of patients, Age, sex, type of CP • Number of patients who received Botox injection = 6 • Male : Female = 5 : 1 • Age • Age range - 3yr 10m to 12yr 6m • Type of CP - Spastic diplegia = 4 • Four limb CP = 2

  6. Age distribution

  7. Number of Botox injection received for each patient during audit period • 1 injection = 5 patients • 2 injections = 1 patient • (given to different sites in 6 months interval)

  8. Number of patients who had previous Botox injections = 5 (83%) & intervals

  9. Tone management clinics (4.3 clinics/patient/year)

  10. Site of injection and dosage(7 injections for 6 patients)

  11. Sedation

  12. Pre injection

  13. Pre/post injection

  14. Overall did the patient achieve desired outcome set prior to treatment? • Comments from clinic letters. • A) Increased mobility. • B) Good response to adductors, lesser extent to hamstrings, much better cared for hygiene. • C) Nappy change easier, less scissored, hip abduction 40-45 degrees. • D) Good effect, better sitting position, more strength, more ability to walk. • Physio assessment in community records.

  15. Outcome • Continued treatment and follow up = 5 • Referral to AlderHey, for assessment of intrathecal Baclofen pump infusion = 2 • Referral to AlderHey orthopaedic Mr Bass for hips = 1 • Transfer (moving out) = 1

More Related